Език: EN EN
← Назад към резултатите
Набира участници Фаза 1 NCT07532135

Safety of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteer

Фаза 1 – тестване на безопасността при малка група хора
Заболявания: Healthy Volunteers Non Diabetic Hyperglycemia

Спонсор: Chulalongkorn University

Налично на: БГ
Обобщение
Volunteers were divided into 2 groups: mulberry leaf extract capsule (DNJ 12mg) group and placebo group. They took the sample 3 times/day for 8 weeks. Complete blood count, Blood urea nitrogen (BUN), Creatinine, Aspartate transaminase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Fasting plasma glucose, HbA1c, and adverse effects were evaluated before and after 4 and 8 weeks.
Описание
Volunteers were divided into 2 groups: mulberry leaf extract capsule (DNJ 12mg) group and placebo group. They took the sample 3 times/day for 8 weeks. Complete blood count, Blood urea nitrogen (BUN), Creatinine, Aspartate transaminase (AST), Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Fasting plasma glucose, HbA1c, and adverse effects were evaluated before and after 4 and 8 weeks. Satisfaction was assessed after 8 weeks.
Кой може да участва
Inclusion Criteria: * Male or female age more than 18 years * No Diabetis mellitus disease and no taking diabetes medication * Blood sugar level less than 126 mg/dl and HbA1C less than 6.5 * Can using Thai language * Willing to participate in the study Exclusion Criteria: * Allergic to mulberry extract * Take mulberry extract in 2 weeks before participate in this study * Take medications that have effect on blood sugar level such as steroid in 2 weeks before participate in this study * Have uncontrolled disease * Have AST, ALT, ALP more than 3 times of normal value, or estimated Glomerular Filtration Rate less than 30 ml/min/1.73 m2) * Pregnancy or lactation
Интервенции
Mulberry Leaf Extract
COMBINATION_PRODUCT
Placebo
OTHER
Места на провеждане 1
Тайланд (1)
Chulalongkorn
Bangkok
Pornanong Aramwit, Ph.D.
Технически детайли
Статус
Набира участници
Фаза
Фаза 1
Вид изследване
INTERVENTIONAL
Пол
Мъже и жени
Минимална възраст
18 Years
Здрави доброволци
Не
Начална дата
01.10.2025
Крайна дата
24.09.2026
Регистрационен номер
NCT07532135
Източник
clinicaltrials.gov
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.